In a 2-year trial with semaglutide 0.5 mg and 1 mg once-weekly injection in adult patients with type 2 diabetes and high cardiovascular risk, diabetic retinopathy complications (which was a 4-component adjudicated endpoint) occurred in patients treated with semaglutide injection (3.0%) compared to placebo (1.8%)
Never change your medication without medical supervision
The FTO rs9939609 and MC4R rs17782313 variants also influence appetite regulation and metabolic set point, affecting how inflammation interacts with weight loss resistance
Williams, is that the second you remove the tool (GLP-1 medication), you'll go right back to feeling hungry and craving unhealthy foods
& Slevin, J
Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date always verify current benefits directly with Blue Cross Blue Shield of Michigan before making any decision